miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint
Authors
Keywords
-
Journal
Nature Communications
Volume 7, Issue -, Pages 11406
Publisher
Springer Nature
Online
2016-05-05
DOI
10.1038/ncomms11406
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miRNAs as prognostic and therapeutic tools in epithelial ovarian cancer
- (2015) Anil Belur Nagaraj et al. Biomarkers in Medicine
- Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia
- (2015) Xi Wang et al. CELLULAR SIGNALLING
- Flightless I Homolog Represses Prostate Cancer Progression through Targeting Androgen Receptor Signaling
- (2015) T. Wang et al. CLINICAL CANCER RESEARCH
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune Checkpoint Protein Inhibition for Cancer: Preclinical Justification for CTLA-4 and PD-1 Blockade and New Combinations
- (2015) Kathryn Baksh et al. SEMINARS IN ONCOLOGY
- The Environment of Regulatory T Cell Biology: Cytokines, Metabolites, and the Microbiome
- (2015) Romy E. Hoeppli et al. Frontiers in Immunology
- The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer
- (2015) Tao Wang et al. Oncotarget
- Quantification of Therapeutic miRNA Mimics in Whole Blood from Nonhuman Primates
- (2014) Kevin Kelnar et al. ANALYTICAL CHEMISTRY
- Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression
- (2014) Chunxiao Xu et al. CANCER CELL
- Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors
- (2014) D. A. Wainwright et al. CLINICAL CANCER RESEARCH
- The Biphasic Expression Pattern of miR-200a and E-cadherin in Epithelial Ovarian Cancer and its Correlation with Clinicopathological Features
- (2014) Shaohua Xu et al. CURRENT PHARMACEUTICAL DESIGN
- Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
- (2014) Liufu Deng et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNA-513 Regulates B7-H1 Translation and Is Involved in IFN- -Induced B7-H1 Expression in Cholangiocytes
- (2014) A.-Y. Gong et al. JOURNAL OF IMMUNOLOGY
- Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs
- (2014) Lei Lu et al. Journal of Translational Medicine
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells
- (2014) Q Cai et al. ONCOGENE
- CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement
- (2014) Chun Jing Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
- (2014) Limo Chen et al. Nature Communications
- Disruption of CD8+ Treg Activity Results in Expansion of T Follicular Helper Cells and Enhanced Antitumor Immunity
- (2014) D. A. Alvarez Arias et al. Cancer Immunology Research
- Therapeutic PD-1 Pathway Blockade Augments with Other Modalities of Immunotherapy T-Cell Function to Prevent Immune Decline in Ovarian Cancer
- (2013) J. Duraiswamy et al. CANCER RESEARCH
- PD-L1 on Tumor Cells Is Induced in Ascites and Promotes Peritoneal Dissemination of Ovarian Cancer through CTL Dysfunction
- (2013) K. Abiko et al. CLINICAL CANCER RESEARCH
- Targeted STAT3 disruption in myeloid cells alters immunosuppressor cell abundance in a murine model of spontaneous medulloblastoma
- (2013) Catalina Abad et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells
- (2012) Dennis Lindau et al. IMMUNOLOGY
- Interferon-γ-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway
- (2011) Jiao Chen et al. IMMUNOBIOLOGY
- Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
- (2011) Sergio A. Quezada et al. IMMUNOLOGICAL REVIEWS
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- The Role of MicroRNAs in Regulatory T Cells and in the Immune Response
- (2011) Tai-You Ha Immune Network
- Cryptosporidium parvumInduces B7‐H1 Expression in Cholangiocytes by Down‐Regulating MicroRNA‐513
- (2009) Ai‐Yu Gong et al. JOURNAL OF INFECTIOUS DISEASES
- Use of a Combination of Approaches to Identify and Validate Relevant Tumor-Associated Antigens and Their Corresponding Autoantibodies in Ovarian Cancer Patients
- (2008) A. Gagnon et al. CLINICAL CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started